investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Mechanism of Meiotic Recombination

Michael Lichten

2 Collaborator(s)

Funding source

National Cancer Institute (NIH)
The goal of this collaboration is to map chromatin modifications induced by meiotic double-strand breaks.

Related projects

Susan Bates

Translational Studies of the Histone Deacetylase Inhibitor Romidepsin

All cancers but non-melanoma skin cancer

Peter Demant

Genetic components of adverse effects of cisplatin therapy

All cancers but non-melanoma skin cancer

Investigator from French National Centre for Scientific Research (CNRS)

Fanconi anemia: a disease model to understand causes and consequences of common fragile site instability

All cancers but non-melanoma skin cancer

Eric S Lander

Large Scale Sequencing and Analysis of Genomes

All cancers but non-melanoma skin cancer

Stuart L Schreiber

Cancer dependencies associated with genomic alterations and targeted by small molecules

All cancers but non-melanoma skin cancer

Elsa Beyer Krall

Identifying STAT3 Co-dependencies in Cancer

All cancers but non-melanoma skin cancer

David L Woodland

Integrating Metabolism and Tumor Biology

All cancers but non-melanoma skin cancer

Anne E Anderson

Signaling pathway dysregulation in epilepsy

All cancers but non-melanoma skin cancer

Jinesh Shailesh Gheeya

The Role of 53BP1 Interacting Proteins in Regulation of DNA Repair Choice

All cancers but non-melanoma skin cancer